About ArcScan
ArcScan is a company based in Golden (United States) founded in 2007.. ArcScan has raised $15.21 million across 4 funding rounds from investors including Shanghai Haohai Biological Technology. The company has 18 employees as of December 31, 2022. ArcScan offers products and services including Insight 100 and EyeSeal. ArcScan operates in a competitive market with competitors including EyeNetra, EYOTO, Smart Vision Labs, PlenOptika and BroadSpot Imaging, among others.
- Headquarter Golden, United States
- Employees 18 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.21 M (USD)
in 4 rounds
-
Latest Funding Round
$11.5 M (USD), Series B
Jul 21, 2021
- Investors
-
Employee Count
18
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ArcScan
ArcScan offers a comprehensive portfolio of products and services, including Insight 100 and EyeSeal. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Robotic ultrasound for precise eye structure scanning and surgical planning.
Device for applications in pIOL sizing and glaucoma management.
Unlock access to complete
Unlock access to complete
Funding Insights of ArcScan
ArcScan has successfully raised a total of $15.21M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $11.5 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $11.5M
-
First Round
First Round
(10 Jun 2008)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series B - ArcScan | Valuation |
investors |
|
| Feb, 2015 | Amount | Series A - ArcScan | Valuation |
investors |
|
| Nov, 2009 | Amount | Seed - ArcScan | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ArcScan
ArcScan has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Shanghai Haohai Biological Technology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Absorbable biomedical materials for surgeries are researched, manufactured, and sold.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ArcScan
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ArcScan
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arcscan Comparisons
Competitors of ArcScan
ArcScan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EyeNetra, EYOTO, Smart Vision Labs, PlenOptika and BroadSpot Imaging, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Refractive errors are measured using smartphone camera attachments.
|
|
| domain | founded_year | HQ Location |
Ophthalmic measurement solutions are developed for eye diagnosis.
|
|
| domain | founded_year | HQ Location |
Refractive errors are tested via smartphone attachment by healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Developer of a medical devices for measuring refractive errors
|
|
| domain | founded_year | HQ Location |
Ophthalmological imaging devices for anterior as well as posterior regions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arcscan
Frequently Asked Questions about ArcScan
When was ArcScan founded?
ArcScan was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is ArcScan located?
ArcScan is headquartered in Golden, United States. It is registered at Golden, Colorado, United States.
Who is the current CEO of ArcScan?
Andrew Levien is the current CEO of ArcScan.
Is ArcScan a funded company?
ArcScan is a funded company, having raised a total of $15.21M across 4 funding rounds to date. The company's 1st funding round was a Seed of $35K, raised on Jun 10, 2008.
How many employees does ArcScan have?
As of Dec 31, 2022, the latest employee count at ArcScan is 18.
What does ArcScan do?
ArcScan has developed an ultrasound-based imaging device for ophthalmologists. The device developed is called Insight 100 that incorporates a transducer to scan the eye in arc-shaped motion. Its curvature approximates the anterior ocular surface to visualize and measure the anterior chamber depth, angle-to-angle width, individual corneal layers, sulcus-to-sulcus width with micron-level precision and repeatability. The device is used for sulcus-to-sulcus width sizing for implantable contact lenses (ICLs), corneal epithelial mapping, aid in the diagnosis of glaucoma and surgical planning. They have received FDA 510(k) clearance and CE Mark for their ArcScan Insight 100 precision ultrasound device.
Who are the top competitors of ArcScan?
What products or services does ArcScan offer?
ArcScan offers Insight 100 and EyeSeal.
Who are ArcScan's investors?
ArcScan has 1 investor. Key investors include Shanghai Haohai Biological Technology.